These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 19830818)
1. Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage. Henry SP; Jang CW; Deng JM; Zhang Z; Behringer RR; de Crombrugghe B Genesis; 2009 Dec; 47(12):805-14. PubMed ID: 19830818 [TBL] [Abstract][Full Text] [Related]
2. Generation of a mouse line harboring a Bi-transgene expressing luciferase and tamoxifen-activatable creER(T2) recombinase in cartilage. Lo Cascio L; Liu K; Nakamura H; Chu G; Lim NH; Chanalaris A; Saklatvala J; Nagase H; Bou-Gharios G Genesis; 2014 Feb; 52(2):110-9. PubMed ID: 24339176 [TBL] [Abstract][Full Text] [Related]
3. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877 [TBL] [Abstract][Full Text] [Related]
5. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2. Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885 [TBL] [Abstract][Full Text] [Related]
7. Non-Invasive Quantification of Cartilage Using a Novel In Vivo Bioluminescent Reporter Mouse. Mailhiot SE; Zignego DL; Prigge JR; Wardwell ER; Schmidt EE; June RK PLoS One; 2015; 10(7):e0130564. PubMed ID: 26151638 [TBL] [Abstract][Full Text] [Related]
8. Aggrecan is required for growth plate cytoarchitecture and differentiation. Lauing KL; Cortes M; Domowicz MS; Henry JG; Baria AT; Schwartz NB Dev Biol; 2014 Dec; 396(2):224-36. PubMed ID: 25446537 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton. Nakamura E; Nguyen MT; Mackem S Dev Dyn; 2006 Sep; 235(9):2603-12. PubMed ID: 16894608 [TBL] [Abstract][Full Text] [Related]
10. Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter. Gebhard S; Hattori T; Bauer E; Schlund B; Bösl MR; de Crombrugghe B; von der Mark K Matrix Biol; 2008 Oct; 27(8):693-9. PubMed ID: 18692570 [TBL] [Abstract][Full Text] [Related]
11. A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme. Inoue S; Inoue M; Fujimura S; Nishinakamura R Genesis; 2010 Mar; 48(3):207-12. PubMed ID: 20127799 [TBL] [Abstract][Full Text] [Related]
12. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Danielian PS; Muccino D; Rowitch DH; Michael SK; McMahon AP Curr Biol; 1998 Dec; 8(24):1323-6. PubMed ID: 9843687 [TBL] [Abstract][Full Text] [Related]
13. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis. Zheng B; Zhang Z; Black CM; de Crombrugghe B; Denton CP Am J Pathol; 2002 May; 160(5):1609-17. PubMed ID: 12000713 [TBL] [Abstract][Full Text] [Related]
15. Aggrecan Hypomorphism Compromises Articular Cartilage Biomechanical Properties and Is Associated with Increased Incidence of Spontaneous Osteoarthritis. Alberton P; Dugonitsch HC; Hartmann B; Li P; Farkas Z; Saller MM; Clausen-Schaumann H; Aszodi A Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30813547 [TBL] [Abstract][Full Text] [Related]
16. A powerful transgenic tool for fate mapping and functional analysis of newly generated neurons. Zhang J; Giesert F; Kloos K; Vogt Weisenhorn DM; Aigner L; Wurst W; Couillard-Despres S BMC Neurosci; 2010 Dec; 11():158. PubMed ID: 21194452 [TBL] [Abstract][Full Text] [Related]
17. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Hayashi S; McMahon AP Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939 [TBL] [Abstract][Full Text] [Related]
18. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity. Undeutsch H; Löf C; Offermanns S; Kero J Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757 [TBL] [Abstract][Full Text] [Related]
19. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium. Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878 [TBL] [Abstract][Full Text] [Related]
20. Transgenic mice expressing a ligand-inducible cre recombinase in osteoblasts and odontoblasts: a new tool to examine physiology and disease of postnatal bone and tooth. Kim JE; Nakashima K; de Crombrugghe B Am J Pathol; 2004 Dec; 165(6):1875-82. PubMed ID: 15579432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]